Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 3,877-3,888 of 10,612

Device study icon

CompletedNCT04142320

Closed-loop Optimized rTMS for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDeviceFrom 18 Years to 65 Years

Countries: United States
Sponsor: Stanford University
Condition: Depression

Device study icon

CompletedNCT05772702

Closed-Loop Transcranial Alternating Current Stimulation for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDeviceFrom 18 Years to 70 Years

Countries: United States
Sponsor: Electromedical Products International, Inc.
Condition: Depression

Drug study icon

CompletedNCT01123408

Clozapine and Olanzapine Treatment of Aggression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Nathan Kline Institute for Psychiatric Research
Condition: Schizophrenia

Other study type icon

CompletedNCT04325386

Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaOtherFrom 22 Years to 85 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Drug study icon

CompletedNCT01639872

Clozapine for Cannabis Use in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia

Drug study icon

CompletedNCT00029458

Clozapine for Treatment-Resistant Mania

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrug

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity

Drug study icon

TerminatedNCT00169039

Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 19 Years to 60 Years

Countries: United States
Sponsor: Harvard Medical School (HMS and HSDM)
Condition: Schizophrenia

Drug study icon

TerminatedNCT00169091

Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Harvard Medical School (HMS and HSDM)
Condition: Schizophrenia

Drug study icon

CompletedNCT00036582

Clozapine vs. Placebo in Treatment-Refractory Bipolarity in Children and Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrug

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity

Behavioral study icon

CompletedNCT06019299

Cluster-Controlled study of Mindfulness-Based Cognitive Therapy Effects on Anxiety and Stress

This study is completed in the United States. It focuses on anxiety.

In United States

AnxietyBehavioralFrom 17 Years to 42 Years

Countries: United States
Sponsor: Michigan State University
Condition: Anxiety

Behavioral study icon

Active Not RecruitingNCT06304467

CM for people with ALD After Liver Transplant

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 99 Years

Countries: United States
Sponsor: Arpan A. Patel, MD
Condition: Addiction

Behavioral study icon

CompletedNCT02143037

CM Treatment for Alcohol Dependence Using New Technology

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: UConn Health
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.